Alizé Pharma presents clinical results from the AZP-531 program

actu_fonda_05
Four projects supported by our foundation
27 May 2015
AlizeePharma_3_actu
Alizé Pharma III raises €1.8 m in its first financing round
16 March 2015
0

Alizé Pharma presents clinical results from the AZP-531 program

Published by Octalfa at
Categories
AlizeePharma_actu
  • Date26 April 2015

The results from two Phase I clinical trials will be presented at the American Diabetes Association.

Related posts

actu_fonda_05
One project supported by our Foundation
2 May 2017

One project supported by our Foundation

Read more
Orega_actu
OREGA Biotech’s interleukin-17 patent to be granted in the US
19 April 2017

OREGA Biotech’s interleukin-17 patent to be granted in the US

Read more
Orega_actu
IL-17B program to be presented at AACR 2017
24 March 2017

IL-17B program to be presented at AACR 2017

Read more